MetaCap

Blackrock Health Sciences Trust (BME)

NYSE: BMEFinanceTrusts Except Educational Religious and CharitableUSD

43.06+0.49 (+1.15%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

BME stock chart

Technical analysis

Key statistics

All statistics
Dividend yield
7.30% ($3.15)
Ex-dividend date
Sep 15, 2026
52-week range
37.37 – 46.43
Day range
42.60 – 43.21
Volume / Avg
40.38K / 41.94K
Beta
—

52-week range

$37.37$46.43

BME stock today

On Oct 7, BME ended the session at $43.06, adding $0.49 (1.15%), versus the S&P 500's 0.22% decline. At this level, BME sits in the middle of its 52-week range of $37.37 to $46.43: 7.3% below the high, set on Aug 25, 2026 and 15.2% above the low. BME is up 4.7% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 14.4%.

At 5.3x trailing earnings, Blackrock Health Sciences trades below the peer-group median of 9.3x. Blackrock Health Sciences pays an annual dividend of $3.15 per share, a 7.30% yield at the current price.

Summary generated from market data by MetaCap's automated system. Methodology

About Blackrock Health Sciences

Company profile
Sector
Finance
Industry
Trusts Except Educational Religious and Charitable
IPO year
2005

Dividends

Dividend history
Annual dividend
$3.15
Last payment
$0.262
Ex-dividend date
Sep 15, 2026

Blackrock Health Sciences peers

Finance sector

Indexes, lists and sector

Blackrock Health Sciences stock FAQ

What is Blackrock Health Sciences's stock price today?

BME last traded at $43.06 as of Oct 7, 4:00 PM EDT, up 1.15% on the day. Prices are delayed at least 15 minutes.

Does Blackrock Health Sciences pay a dividend?

Yes. Blackrock Health Sciences pays $3.15 per share annually, a 7.30% yield. The most recent dividend of $0.262 had an ex-dividend date of Sep 15, 2026.

What is BME's P/E ratio?

BME trades at a trailing P/E ratio of 5.34, compared with a median of 9.3 for its closest peers.

What is the BME 52-week high?

The 52-week high for BME is $46.43 and the 52-week low is $37.37. The stock is currently 7.3% below its high.

Compare BME